|
AGL (Chr1)
|
Amylo-Alpha-1, 6-Glucosidase, 4-Alpha-Glucanotransferase
|
27
|
Chr2:1 / Chr4:2 / Ch6:2 / Chr16:22
|
CHST5/ADAT1/GABARAPL2/LRP2/SCGN/TMEM231
|
|
ASCL4 (Chr12)
|
Achaete-Scute Complex-Like 4
|
24
|
Chr6:5 / Chr7:1 / Ch9:1 / Chr16:2 / Chr17:3 / Chr18:12
|
MPG/ASXL3/ATP6V0A1/EEPD1/MPG/NAGLU
|
|
C21orf96/RUNX-IT1 (Chr21)
|
RUNX1 Intronic Transcript 1 (Non-Protein Coding)
|
3
|
Chr5:1 / Chr9:1 / Chr13:1
|
PDZD2
|
|
C9orf19/GLIPR2 (Chr9)
|
Glioma Pathogenesis-Related Protein 2
|
20
|
Chr1:2 / Chr2:6 / Chr5, 7, 11 and 14 : 1 each / Chr8:3 / Chr12:2 / Chr13:3
|
ARRB1 / CAPN2 / CFLAR/ TP53BP2
|
|
CRYGS (Chr3)
|
crystallin, gamma S
|
41
|
Chr1:30 Chr2 and Chr6: 3 each Chr5:2 Chr8, 9 and 14: 1 each
|
CAMTA1
|
|
CTSK (Chr1)
|
Cathepsin X
|
19
|
Chr1,9 and 16:1 each/ Chr5:6/ Chr7, 10 and 17: 2 each/ Chr14: 4 each
|
CRISPLD2/FHAD1/IDE/PTPRD/RBFOX3/SNX6/SP4
|
|
DTX1 (Chr12)
|
deltex homolog 1 (Drosophila)
|
31
|
Chr 6:5 / Chr 9:1 / Chr 14:2 / Chr 21:23
|
TIAM1
|
|
FOXQ1 (Chr6)
|
Forkhead Box Protein Q1
|
21
|
Chr 1:6 / Chr 3:10 / Chr 5 and 6:1 each / Chr 16:3
|
FLYWCH1/GNG4/PARK2
|
|
GABARAPL1 (Chr12)
|
GABA(A) Receptor-Associated Protein-Like 1
|
7
|
Chr 2:5 / Chr 6 and 14:1 each
|
STRN3
|
|
JAK1 (Chr1)
|
Janus Kinase 1
|
44
|
Chr 1:8 / Chr 2, 3, 6 and 10:2 each/ Chr 4, 12 and 13:1 each / Chr 5:12 / Chr 8:3 / Chr 14:10
|
GPATCH2/ SLC6A15/ TFDP2
|
|
MAPKAPK2 (Chr1)
|
Mitogen-Activated Protein Kinase-Activated Protein Kinase 2
|
3
|
Chr11:2 / Chr 5:1
|
ARRB1/ OPCML
|
|
MGC16186 (Chr10)
|
DPY30 Domain Containing 2
|
10
|
Chr 4:4 / Chr 7, 9 and 22:1 each / Chr 10:3
|
MANBA/ MYO18B
|
|
MGC16385 (Chr16)
|
CENPB DNA-Binding Domains Containing 1
|
18
|
Chr 4:4 / Chr 5:2 / Chr 17 and 22:1 each / Chr 14:10
|
AGXT2L1/ GIP / ITPK1/PDE6A
|
|
MTND4 (mitochondrial)
|
Mitochondrially Encoded NADH Dehydrogenase
|
16
|
Chr 1:8 / Chr 4, 6, 8, 9 and 14:1 each / Chr 10:3
|
GNG4/ GPATCH2/ SH2D4B
|
|
MTND5 (mitochondrial)
|
Mitochondrially Encoded NADH Dehydrogenase 5
|
10
|
Chr 9 and 10:1 / Chr 14:8
|
PTGDR / SH2D4B
|
|
MTVR1 (Chr11)
|
Mammary Tumor Virus Receptor Homolog 1
|
28
|
Chr 2:23 / Chr 6 and 10:1 each / Chr 7:3
|
NIF3L1/ C7orf42/ CFLAR/ FAM126B/NIF3L1/ORC2
|
|
MUC15 (Chr11)
|
Mucin 15, Cell Surface Associated
|
16
|
Chr 1:8 / Chr 2:2 / Chr 9, 15 and 21:1 each / Chr 11:3
|
CAPN2/CGNL1/TP53BP2
|
|
MXD4 (Chr4)
|
MAX dimerization protein 4
|
13
|
Chr 2:3 / Chr 4, 5, 10 and 17:1 each / Chr 9:2 / Chr 16:4
|
MPG/NPRL3/CCDC46/KANK1/USP34
|
|
NADSYN1 (Chr11)
|
NAD Synthetase 1
|
38
|
Chr 2:32 / Chr 13:1 / Chr 16:5
|
ERBB4/ FHAD1/ GPATCH2
|
|
PIP5K1B (Chr9)
|
Phosphatidylinositol 4-Phosphate 5-Kinase Type-1 Beta
|
75
|
Chr 1:2 / Chr 2: 65 / Chr 6 and 14:1 each / Chr 7:4 / Chr 13:2
|
NIF3L1/ ABCC4/ CFLAR/ FAM126B/ GPATCH2/NDUFB3/NIF3L1/ORC2/PPIL3/SMYD3/TSGA14
|
|
PODLX2 (Chr3)
|
podocalyxin-like 2
|
44
|
Chr 3 and 20:1 each / Chr 11:39 / Chr 11:3
|
LDLRAD3
|
|
ROPN1 (Chr3)
|
Rhophilin Associated Tail Protein 1
|
7
|
Chr 1:2 / Chr 3:3 / Chr 4 and 13:1
| |
|
SLC35D2 (Chr9)
|
Solute Carrier Family 35 Member D2
|
18
|
Chr 4 and 10:3 each / Chr 5:10 / Chr 13 and 22:1 each
|
ABLIM2/ MANBA/ TTLL1
|
|
TDE1 (Chr20)
|
Tumor Differentially Expressed 1
|
39
|
Chr 1:12 / Chr 2, 10and 14:1 each / Chr 3:6 / Chr 5:9 / Chr 8:7 / Cht 15:2
|
FHAD1/PPCS/ SMYD3/ZMYND12
|
|
TWSG1 (Chr18)
|
Twisted Gastrulation Protein Homolog 1
|
8
|
Chr 2:5 / Chr 6:3
|
CLK1/ FAM126B/
|
|
VIAAT (Chr20)
|
Solute Carrier Family 32 Member 1
|
55
|
Chr 6 and 10:4 each / Chr 12:1 / Chr 13: 3 / Chr 14:41 / Chr 16:2
|
SNX6/ STRN3/ RSU1
|
|
VPS39 (Chr15)
|
Vacuolar Protein Sorting 39
|
14
|
Chr 2, 3 and 5: 3 each / Chr 4, 11, 13, 14 and 22:1 each
|
ACTN1/ ARRB1/ GRM7/ SEZ6L
|
| |
Total
|
648
| | |
